NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹638 Cr | ₹486 Cr | ₹606 Cr | ₹604 Cr | ₹1,030 Cr |
What is the latest Short Term Loans and Advances ratio of NATCO PHARMA ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹638 Cr |
Mar2023 | ₹486 Cr |
Mar2022 | ₹606 Cr |
Mar2021 | ₹604 Cr |
Mar2020 | ₹1,030 Cr |
How is Short Term Loans and Advances of NATCO PHARMA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹638 Cr | 31.43 | |
Mar2023 | ₹486 Cr | -19.89 | |
Mar2022 | ₹606 Cr | 0.41 | |
Mar2021 | ₹604 Cr | -41.39 | |
Mar2020 | ₹1,030 Cr | - |
Compare Short Term Loans and Advances of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,535.1 Cr | 6% | 17.4% | -19.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 6% |
17.4% |
-19.4% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses